Research on Acute Compartment Syndrome after Femoropopliteal Arterial Injuries
ACS After Femoropopliteal Arterial Injuries
This study looks at how often people develop Acute Compartment Syndrome after injuries to the femoropopliteal artery and what that means for their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hebei Medical University Third Hospital Academic / other |
| Locations | 1 site (Shijiazhuang, Hebei) |
| Trial ID | NCT05030259 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the occurrence of Acute Compartment Syndrome (ACS) following femoropopliteal arterial injuries in adults. It focuses on understanding the implications of prolonged ischemia and the need for fasciotomy in the treatment of this condition. The study aims to gather data on patient outcomes and treatment controversies associated with ACS. By analyzing these cases, the research seeks to provide insights into optimal management strategies for affected patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have sustained femoropopliteal arterial injuries.
Not a fit: Patients who did not survive to discharge or those who underwent primary amputation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment protocols for patients suffering from Acute Compartment Syndrome after arterial injuries.
How similar studies have performed: While there is ongoing debate regarding the treatment of ACS, this study addresses a specific aspect of the condition, making it a potentially novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with femoropopliteal arterial injuries * patients older than 18 years Exclusion Criteria: * Patients who did not survive to discharge * Patients with primary amputation * patients younger than 18 years
Where this trial is running
Shijiazhuang, Hebei
- the Third Hospital of Hebei Medical Univesity — Shijiazhuang, Hebei, China (Recruiting)
Study contacts
- Principal investigator: Hou Zhiyong, Doctor — Hebei Medical University Third Hospital
- Study coordinator: Guo Jialiang, Doctor
- Email: drjlguo86@gmail.com
- Phone: 18203222090
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.